EyePoint Pharmaceuticals, Inc. (NasdaqGM:EYPT) will look for acquisitions. EyePoint Pharmaceuticals, Inc. has filed a Follow-on Equity Offering in the amount of $20 million. EyePoint intends to use the proceeds for general corporate purposes, which may include working capital, capital expenditures, research and development expenditures, clinical trial expenditures, commercial expenditures, debt service costs and repayment, acquisitions of new technologies, products or businesses, and investments.